SIGNATURE IN 2019 OF AN EXCLUSIVE AND WORLDWIDE LICENSING AGREEMENT WITH SATT OUEST VALORISATION AND AP-HP
ADCIS, a company specialized in image processing and analysis and Evolucare, a key company in the hospital information system, announce the signing of an exclusive and worldwide licensing agreement with SATT (*) Ouest Valorisation and AP-HP at the CES (Consumer Electronics Show) 2019 in Las Vegas. As part of the SATT-led HealthTech delegation, the partners are taking advantage of a unique opportunity to collectively expand their international presence to mark, during a high point on Thursday, January 10, a lasting collaboration for automated screening for diabetic retinopathy and, in the near future, other eye diseases.
The innovative application, named OphtAI, is an artificial intelligence resulting from three years of collaborative research between researchers, clinicians and industrialists. Combined with the Evolucare imaging and tele-ophthalmology platform, OphtAI will provide better care for almost half a billion people at risk worldwide.
